Fifth Third Bancorp (FITB) came out with quarterly earnings of $0.9 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.86 per share a year ago.

The Dividend Harvesting Portfolio is thriving, generating strong recurring income and capital appreciation, with forward dividend income nearing $2,400 and a yield over 8%. My disciplined weekly allocation and diversified approach—spanning 102 positions—have mitigated downside risk and steadily grown income, even during market uncertainty. Recent additions to Bristol Myers Squibb, BP, and BSTZ reflect my focus on undervalued, high-yield opportunities positioned for growth amid potential Fed rate cuts.

Self-service portal empowers restaurant partners with real-time insights and streamlined deal management capabilities New tiered subscription model creates additional revenue opportunities while enhancing value proposition for Restaurant.com's 184,000+ restaurant partners SCHAUMBURG, IL, July 17, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced the launch of Restaurant.com's new Restaurant Management Center (RMC), a comprehensive self-service portal that transforms how restaurant partners manage their presence on the nation's largest restaurant-focused digital deals platform. Key Highlights of the Restaurant Management Center Launch …

CENTENNIAL, CO / ACCESS Newswire / July 17, 2025 / NioCorp Developments Ltd.("NioCorp" or the "Company") (NASDAQ:NB) today announced the pricing of its previously announced public offering in the United States (the "Offering").

June Revenue Hits $27.3 Million; Globetopper Acquisition Positions Company to Reach $400 Million Run Rate in Q3 – Ahead of Plan NEW YORK , July 17, 2025 /PRNewswire/ -- IQSTEL Inc. (NASDAQ: IQST) is pleased to announce preliminary unaudited revenue of $128.8 million for the first half of 2025 (H1). June alone contributed $27.3 million , a significant increase from May's $23.7 million , highlighting the company's accelerating commercial momentum across its global telecom and tech operations.

- Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients - Prolonged and Durable Complete Responses (CRs) Observed in Two of Ten Refractory Ewing Sarcoma Patients - Two Additional Patients Had Durable Stable Disease in Notoriously Difficult-to-Treat Cancer - Confirmed Partial Response (PR) in a patient with a desmoplastic small-round-cell tumor (DSRCT) - Company Initiating Planning of Phase 2 Trial of Elraglusib in Children, Adolescents, and Adults with Refractory/Resistant Ewing Sarcoma CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing …

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Paul Meeks, Managing Director at Water Tower Research, tells 'Worldwide Exchange' that Netflix's earnings growth is priced in, with live events and strong content driving future success.

ST. LOUIS , July 17, 2025 /PRNewswire/ -- On Thursday, July 31, 2025, Peabody (NYSE: BTU) will announce results for the quarter ended June 30, 2025. A conference call with management is scheduled for 10 a.m.

$48.7 million privately negotiated convertible notes exchanges.$330 million exchange offer of senior secured notes and solicitation of consentsAgreement in principle to extend revolving credit agreementAgreement in principle to amend and extend the CGIC noteAgreement in principle to extend Spectrum notesAgreement in principle to amend and extend the R2 Technologies note

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

ASML (NASDAQ:ASML), the Dutch semiconductor equipment giant, saw its stock fall about 11% following its Q2 2025 earnings report, as the company warned that it could no longer guarantee that its topline would grow in 2026, overshadowing what was otherwise a strong quarter. Revenue came in at 7.7 billion euros ($8.9 billion), at the upper end of guidance, while net income stood at 2.3 billion euros ($2.67 billion).

XIAMEN, China , July 17, 2025 /PRNewswire/ -- On July 9, Jay Chou officially announced his presence on Douyin, under the account name "周同学" (Mr. Chou) , identifying himself as a singer.

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.

Financial advisors often find themselves navigating a complex landscape of client needs and market opportunities. One area that's gaining increasing traction, yet remains underserved, is Jewish values investing.

SK Telecom is undervalued, trading at 4x FWD EBITDA versus peers at 8.5x, with strong FCF growth potential from ongoing capital expenditures. Strategic disposals and alliances, including recent subsidiary sales, are expected to lower net debt and enhance stock valuation in the near future. New AI-driven products, cloud services, and 85,000 Wi-Fi access points position SKM for accelerated revenue and FCF growth despite competitive and regulatory risks.

PHILADELPHIA, July 17, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC , a Philadelphia-based law firm focused on investor protection, is investigating claims against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket Pharmaceuticals” or the “Company”) for potential violations of federal securities laws. A class action has been filed over allegations that the Company concealed safety concerns tied to its RP-A501 trial, leading to steep investor losses.

For many dividend investors, finding the right mix of yield and long-term capital appreciation upside is very difficult.

A Reddit poster took a big loss on Pfizer. They needed to dump some shares because they occupied a huge chunk of their portfolio.